4,5,9,10-Tetrahydro-1,4-ethanobenz[b]quinolizine as a prodrug for its quinolizinium cation as a ligand to the open state of the TCP-binding site of NMDA receptors

Shigeki Sasaki, Takahiro Kanda, Nobuyasu Ishibashi, Fumihiko Yamamoto, Terushi Haradahira, Takashi Okauchi, Jun Meda, Kazutoshi Suzuki, Minoru Maeda

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A new derivative of 4,5,9,10-tetrahydro-1,4-ethanobenz[b]quinolizine (2) has been designed as a prodrug for its quinolizinium cation (1) that is a potent antagonist of the TCP-binding site of NMDA receptors at the open state. The 11C-labeled 2 showed high accumulation of radioactivity in the brain in an in vivo biodistribution study. The speculation of 2 as a prodrug of 1 has been proven by the fact that 1 was observed in a high ratio to 2 in an analysis by RP-HPLC of the brain homogenates.

Original languageEnglish
Pages (from-to)519-521
Number of pages3
JournalBioorganic and Medicinal Chemistry Letters
Volume11
Issue number4
DOIs
Publication statusPublished - Feb 26 2001

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of '4,5,9,10-Tetrahydro-1,4-ethanobenz[b]quinolizine as a prodrug for its quinolizinium cation as a ligand to the open state of the TCP-binding site of NMDA receptors'. Together they form a unique fingerprint.

  • Cite this